Skip to Content

WPI 1.5 (Paliperidone Extended-Release 1.5 mg)

Pill with imprint WPI 1.5 is Beige, Round and has been identified as Paliperidone extended-release 1.5 mg. It is supplied by Actavis Pharma, Inc..

Paliperidone is used in the treatment of schizoaffective disorder; schizophrenia; borderline personality disorder; autism; bipolar disorder (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1.5

Paliperidone extended-release

WPI 1.5
1.5 mg
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.